Researchers Say Derived Spinal Atrophy iPS Cells Offer Model for Genetic Disease Studies

This work marks the first study to demonstrate that human iPS cells can be used to model the specific pathology seen in a genetically inherited disease, representing a potentially valuable resource to study disease mechanisms, screen new drug compounds, and develop new therapies, a University of Wisconsin investigator told CBA News this week.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.